Skip to main content

Table 2 Outcomes following transarterial chemoembolization for metastatic neuroendocrine tumors

From: Transarterial chemoembolization is ineffective for neuroendocrine tumors metastatic to the caudate lobe: a single institution review

Variables

Caudate lobe metastases ( n= 45)

Number of caudate lobe metastases ( n= 41)

P value

Median length of stay in days (range)

5.9 (1 to 27)

4.7 (1 to 17)

0.23

Radiographic responsea

37/45 (82.2%)

34/41 (82.9%)

.84

Mean duration of radiographic response in months (range)

14.5 (3 to 61)

12.9 (2 to 71)

0.41

Symptom responseb

29/45 (64.4%)

23/41 (56.1%)

.51

Median duration of symptomatic response in weeks (range)

12 (2 to 43)

12.5 (2 to 73)

0.30

Biochemical responsec

40/41 (97.6%)

32/36 (88.9%)

0.18*

Median duration of biochemical response in weeks (range)

13 (1.5 to 53)

17.4 (2.1 to 37.8)

0.91

  1. Percentages are calculated based upon the number of patients with complete data. aDenominators vary based upon availability of post-TACE data; bdenominators based upon number of patients with carcinoid syndrome prior to TACE; cdenominators vary based upon availability of pancreastatin levels.*Fisher’s exact probability test.